2-(6-((2-(3-hydroxypropyl)-5-methylphenylamino)methyl)-2-(3-morpholin-4-ylpropylamino)benzoimidazol-1-ylmethyl)-6-methylpyridin-3-ol,
TMC 353121,
TMC-353121,
TMC353121,
TMC353121,
857066-90-1,
TMC-353121,
UNII-538EBT31Z1,
538EBT31Z1,
2-[[6-[[[2-(3-Hydroxypropyl)-5-Methylphenyl]amino]methyl]-2-[[3-(4-Morpholinyl)propyl]amino]-1h-Benzimidazol-1-Yl]methyl]-6-Methyl-3-Pyridinol,
2-[[6-[[[2-(3-Hydroxypropyl)-5-methylphenyl]amino]methyl]-2-[[3-(morpholin-4-yl)propyl]amino]benzimidazol-1-yl]methyl]-6-methylpyridin-3-ol,
2-[[6-[[2-(3-hydroxypropyl)-5-methylanilino]methyl]-2-(3-morpholin-4-ylpropylamino)benzimidazol-1-yl]methyl]-6-methylpyridin-3-ol,
SCHEMBL540713,
CHEMBL408963,
DTXSID10235008,
C32H42N6O3,
4123AH,
ZINC29134397,
CS-0682,
NCGC00379057-01,
HY-11097,
TMC 353121;TMC-353121,
A11585,
W-5768,
D02TNS,
DKORMNNYNRPTBJ-UHFFFAOYSA-N,
CID11249932,
JNJ-2408068,
CID 11249932,
A3878,
Viral fusion inhibitor (RSV infection), J&J,
R-170591,
Viral fusion inhibitor (respiratory syncytial virus infection), J&J,
Tm3,